KR Choksey's research report on Colgate Palmolive (India)
In Q3FY23, CLGT reported revenue from operations of INR 12,913 mn (+0.9% YoY/ -6.9% QoQ). Demand for oral care products continued to be subdued during the quarter due to adverse macro factors. For 9MFY23, revenue from operations was INR 38,756 mn (+2.0% YoY). EBITDA for the quarter declined by 5.0% YoY/ 11.4% QoQ to INR 3,615 mn. EBITDA margin contracted by 174 bps YoY/ 141 bps QoQ to 28.0%. For 9MFY23, EBITDA and EBITDA margin declined by 3.6%/ 166 bps YoY, respectively. Net Profit for Q3FY23 declined by 3.6% YoY/ 12.5% QoQ to INR 2,432 mn. Net Profit margin contracted by 87 bps YoY/ 120 bps QoQ to 18.8%. For 9MFY23, Net Profit declined by 3.2% YoY to INR 7,309 mn and Net Profit margin declined by 101 bps to 18.9%.
Outlook
We apply P/E multiple of 35.0x on FY25E EPS of INR 46.8 and arrive at a target price of INR 1,638 per share (reduced from INR 1,753 earlier), having an upside potential of 11.9% from CMP. Accordingly, we maintain our rating at “Accumulate” on the shares of Colgate Palmolive India.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.